Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Quantum-Coherent Optoelectronic Platform for Ultra-Early Detection of Oncometabolites

Objetivo

Early cancer detection remains a critical unmet medical need, as most diagnostic technologies only identify tumours after macroscopic lesions have formed. Mutations in isocitrate dehydrogenase (IDH1/2) produce the oncometabolite D-2-hydroxyglutarate (D-2HG), an early biochemical marker detectable in blood and urine. Current detection methods rely on chromatographic or enzymatic assays that require complex equipment, extensive sample preparation, and often struggle with sensitivity at very low concentrations. Q-SENSE-EDO introduces a novel diagnostic approach based on quantum-engineered molecular sensing. Instead of measuring fluorescence intensity or relying on genomic amplification, the proposal aims to detect biological targets by observing changes in excited-state dynamics within molecular systems. The interaction between D-2HG and a specially engineered molecular interface is expected to cause measurable changes in excited-state lifetime, vibronic coherence, and non-radiative decay pathways. These perturbations can be measured using time-resolved optoelectronic readouts, offering a physics-based sensing mechanism. The project builds on discoveries from the ERC Advanced Grant EXCITED, which demonstrated the ability to engineer molecular sensitizers with controlled excited-state dynamics and coherent photophysical behaviour. Q-SENSE-EDO will translate these findings into a proof-of-concept diagnostic platform by developing biofunctional quantum-coherent dyes, characterising their interaction with D-2HG using multidimensional time-resolved spectroscopy, and implementing a simplified lifetime-based classification model compatible with clinical instruments. If successful, Q-SENSE-EDO will define quantum-state perturbation as a new biosensing principle, opening a technological frontier at the intersection of quantum chemistry, photonics, and biomedical diagnostics while establishing a robust intellectual property portfolio for quantum-enabled sensing technologies.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2026-POC

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA
Aportación neta de la UEn
€ 150 000,00
Coste total
Sin datos

Beneficiarios (1)